首页 | 本学科首页   官方微博 | 高级检索  
     

近距离治疗肿瘤的放射性粒子研究进展
引用本文:李忠勇,高惠波,金小海,陈大明.近距离治疗肿瘤的放射性粒子研究进展[J].同位素,2011,24(2):118-123.
作者姓名:李忠勇  高惠波  金小海  陈大明
作者单位:原子高科股份有限公司,北京102413
摘    要:放射性粒子近距离治疗肿瘤是现代肿瘤治疗的重要手段之一.其中,125I粒子和103Pd粒子的应用较成熟,125I粒子主要用于治疗分化较好、增殖较慢的肿瘤,103Pd粒子在增殖较快的肿瘤治疗中具有明显的优势.粒子链和复合粒子是粒子研究的重要方向,尤其是103Pd-125I复合粒子源能够结合两种核素的特性,工艺上具备可行性,...

关 键 词:恶性肿瘤  近距离治疗  放射性粒子  103Pd-125I复合粒子

Research Progress in Radioactive Seed for Brachytherapy
LI Zhong-yong,GAO Hui-bo,JIN Xiao-hai,Chen Da-ming.Research Progress in Radioactive Seed for Brachytherapy[J].Isotopes,2011,24(2):118-123.
Authors:LI Zhong-yong  GAO Hui-bo  JIN Xiao-hai  Chen Da-ming
Affiliation:Atom High Tech Co. Ltd., Beijing 102413, China
Abstract:Brachytherapy is one of the most important technologies in the modern tumors treatment.125I seed and 103Pd seed are applied widely and maturely,103Pd seed is considered to be more effective in treating aggressive and fast growing tumors,and 125I seed has obvious advantages on slower growing tumors.Seed strand and hybrid seed are two important direction of the research concerning the brachytherapy seed,especially in the 103Pd-125I composite seed can combine the characteristics of the two kinds of nuclides.Th...
Keywords:malignant tumor  brachytherapy  radioactive seed  103Pd-125I hybrid seed  
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《同位素》浏览原始摘要信息
点击此处可从《同位素》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号